A Phase 1 Mass Balance Study of TS-172 in Healthy Adult Subjects
Latest Information Update: 18 Nov 2024
Price :
$35 *
At a glance
- Drugs TS-172 (Primary)
- Indications Hyperphosphataemia
- Focus Pharmacokinetics
- Sponsors Taisho Pharmaceutical
- 13 Nov 2024 Status changed from recruiting to completed.
- 02 Oct 2024 Status changed from not yet recruiting to recruiting.
- 30 Sep 2024 New trial record